About
Looking for more information?
Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
INVESTOR PRESENTATION - Anatara Lifesciences Ltd
Anatara Lifesciences Ltd
Health
Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Company's initial focus is the development and commercialisation of Detach, which is a natural, plant-based, non-antibiotic therapy that prevents and treats diarrhoea in pigs.
Read moreMarket Cap
$13.03m
Price at Close
$0.185
4w avg. Volume
52.63k
4w avg. Turnover
$9.18k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| -10.53% | 14 Dec 2020 |
| 0.00% | 07 Dec 2020 |
| 0.00% | 03 Dec 2020 |
| 0.00% | 03 Dec 2020 |
| 0.00% | 03 Dec 2020 |
| 0.00% | 03 Dec 2020 |
| 0.00% | 03 Dec 2020 |
| -5.13% | 29 Nov 2020 |
| 0.00% | 26 Nov 2020 |
| 0.00% | 26 Nov 2020 |
Market Data
Current Price
$0.185
52WK HIGH
$0.45
52WK LOW
$0.13
1YR RETURN
-37.29%
1YR RETURN VS. SECTOR
-74.80%
90 DAY RETURN
-7.50%
ASX RANK
1,709
/2,047
SECTOR RANK
156
/168
SHARES OUTSTANDING
70.45m
Anatara Lifesciences Ltd
Health
Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Company's initial focus is the development and commercialisation of Detach, which is a natural, plant-based, non-antibiotic therapy that prevents and treats diarrhoea in pigs.
Read moreMarket Cap
$13.03m
Price at Close
$0.185
4w avg. Volume
52.63k
4w avg. Turnover
$9.18k
ASX:ANR is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia